{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:41:29Z","timestamp":1766050889981,"version":"3.41.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,8]]},"DOI":"10.7759\/cureus.85554","type":"journal-article","created":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T12:01:21Z","timestamp":1749384081000},"source":"Crossref","is-referenced-by-count":1,"title":["The Impact of Volume Removal by Hemodialysis on Elevated NT-proBNP Levels in Patients With Hypervolemia"],"prefix":"10.7759","author":[{"given":"Mohammad","family":"Tinawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahar","family":"Bastani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118162","article-title":"Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an \"emergency\" cardiac hormone against ventricular overload","volume":"96","author":"Nakagawa O","year":"1995","unstructured":"Nakagawa O, Ogawa Y, Itoh H, et al.. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an \"emergency\" cardiac hormone against ventricular overload. J Clin Invest. 1995, 96:1280-7. 10.1172\/JCI118162","journal-title":"J Clin Invest"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020233","article-title":"Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure","volume":"347","author":"Maisel AS","year":"2002","unstructured":"Maisel AS, Krishnaswamy P, Nowak RM, et al.. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002, 347:161-7. 10.1056\/NEJMoa020233","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.12.032","article-title":"The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study","volume":"95","author":"Januzzi Jr JL","year":"2005","unstructured":"Januzzi Jr JL, Camargo CA, Anwaruddin S, et al.. The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol. 2005, 95:948-54. 10.1016\/j.amjcard.2004.12.032","journal-title":"Am J Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008010012","article-title":"Use of cardiac biomarkers in end-stage renal disease","volume":"19","author":"Wang AY","year":"2008","unstructured":"Wang AY, Lai KN. Use of cardiac biomarkers in end-stage renal disease. J Am Soc Nephrol. 2008, 19:1643-52. 10.1681\/ASN.2008010012","journal-title":"J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2003.030692","article-title":"Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis","volume":"50","author":"Wahl HG","year":"2004","unstructured":"Wahl HG, Graf S, Renz H, Fassbinder W. Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis. Clin Chem. 2004, 50:1071-4. 10.1373\/clinchem.2003.030692","journal-title":"Clin Chem"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.04.007","article-title":"N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis","volume":"46","author":"DeFilippi CR","year":"2005","unstructured":"DeFilippi CR, Fink JC, Nass CM, Chen H, Christenson R. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis. Am J Kidney Dis. 2005, 46:35-44. 10.1053\/j.ajkd.2005.04.007","journal-title":"Am J Kidney Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002087","article-title":"N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis","volume":"71","author":"Madsen LH","year":"2007","unstructured":"Madsen LH, Ladefoged S, Corell P, Schou M, Hildebrandt PR, Atar D. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. Kidney Int. 2007, 71:548-54. 10.1038\/sj.ki.5002087","journal-title":"Kidney Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.08.017","article-title":"Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients","volume":"50","author":"Satyan S","year":"2007","unstructured":"Satyan S, Light RP, Agarwal R. Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. Am J Kidney Dis. 2007, 50:1009-19. 10.1053\/j.ajkd.2007.08.017","journal-title":"Am J Kidney Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2006.08.021","article-title":"Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results","volume":"152","author":"Wu AH","year":"2006","unstructured":"Wu AH. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results. Am Heart J. 2006, 152:828-34. 10.1016\/j.ahj.2006.08.021","journal-title":"Am Heart J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2010.51.2.151","article-title":"Interpretation and use of natriuretic peptides in non-congestive heart failure settings","volume":"51","author":"Tsai SH","year":"2010","unstructured":"Tsai SH, Lin YY, Chu SJ, Hsu CW, Cheng SM. Interpretation and use of natriuretic peptides in non-congestive heart failure settings. Yonsei Med J. 2010, 51:151-63. 10.3349\/ymj.2010.51.2.151","journal-title":"Yonsei Med J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.08.051","article-title":"Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study","volume":"47","author":"Anwaruddin S","year":"2006","unstructured":"Anwaruddin S, Lloyd-Jones DM, Baggish A, et al.. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. J Am Coll Cardiol. 2006, 47:91-7. 10.1016\/j.jacc.2005.08.051","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000471815","article-title":"Brain natriuretic peptide is a marker of fluid overload in incident hemodialysis patients","volume":"7","author":"Chazot C","year":"2017","unstructured":"Chazot C, Rozes M, Vo-Van C, et al.. Brain natriuretic peptide is a marker of fluid overload in incident hemodialysis patients. Cardiorenal Med. 2017, 7:218-26. 10.1159\/000471815","journal-title":"Cardiorenal Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft054","article-title":"B-type natriuretic peptide is not a volume marker among patients on hemodialysis","volume":"28","author":"Agarwal R","year":"2013","unstructured":"Agarwal R. B-type natriuretic peptide is not a volume marker among patients on hemodialysis. Nephrol Dial Transplant. 2013, 28:3082-9. 10.1093\/ndt\/gft054","journal-title":"Nephrol Dial Transplant"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.646402","article-title":"Association of N-terminal pro-brain natriuretic peptide with volume status and cardiac function in hemodialysis patients","volume":"8","author":"Wang Y","year":"2021","unstructured":"Wang Y, Cao X, Yu J, et al.. Association of N-terminal pro-brain natriuretic peptide with volume status and cardiac function in hemodialysis patients. Front Cardiovasc Med. 2021, 8:10.3389\/fcvm.2021.646402","journal-title":"Front Cardiovasc Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2007.01785.x","article-title":"Cardiac biomarkers and survival in haemodialysis patients","volume":"37","author":"Sommerer C","year":"2007","unstructured":"Sommerer C, Beimler J, Schwenger V, Heckele N, Katus HA, Giannitsis E, Zeier M. Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest. 2007, 37:350-6. 10.1111\/j.1365-2362.2007.01785.x","journal-title":"Eur J Clin Invest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm700","article-title":"Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis","volume":"23","author":"David S","year":"2008","unstructured":"David S, K\u00fcmpers P, Seidler V, Biertz F, Haller H, Fliser D. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis. Nephrol Dial Transplant. 2008, 23:1370-7. 10.1093\/ndt\/gfm700","journal-title":"Nephrol Dial Transplant"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/BF03343804","article-title":"Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis","volume":"24","author":"Clerico A","year":"2001","unstructured":"Clerico A, Caprioli R, Ry SD, Giannessi D. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis. J Endocrinol Invest. 2001, 24:24-30. 10.1007\/BF03343804","journal-title":"J Endocrinol Invest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1271508","article-title":"Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients","volume":"12","author":"Zoccali C","year":"2001","unstructured":"Zoccali C, Mallamaci F, Benedetto FA, et al.. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol. 2001, 12:1508-15. 10.1681\/ASN.V1271508","journal-title":"J Am Soc Nephrol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43253-z","article-title":"Characterisation of N-terminal pro-brain natriuretic peptide in dialysis patients and its reduced prognostic significance in the elderly","volume":"9","author":"Sato Y","year":"2019","unstructured":"Sato Y, Ishizaki Y, Aso K, et al.. Characterisation of N-terminal pro-brain natriuretic peptide in dialysis patients and its reduced prognostic significance in the elderly. Sci Rep. 2019, 9:10.1038\/s41598-019-43253-z","journal-title":"Sci Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.082313","article-title":"Raised plasma N-terminal pro-B-type natriuretic peptide concentrations predict mortality and cardiac disease in end-stage renal disease","volume":"92","author":"Sharma R","year":"2006","unstructured":"Sharma R, Gaze DC, Pellerin D, et al.. Raised plasma N-terminal pro-B-type natriuretic peptide concentrations predict mortality and cardiac disease in end-stage renal disease. Heart. 2006, 92:1518-9. 10.1136\/hrt.2005.082313","journal-title":"Heart"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2004.035741","article-title":"Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death","volume":"50","author":"Apple FS","year":"2004","unstructured":"Apple FS, Murakami MM, Pearce LA, Herzog CA. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem. 2004, 50:2279-85. 10.1373\/clinchem.2004.035741","journal-title":"Clin Chem"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn278","article-title":"Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients","volume":"29","author":"Winkler K","year":"2008","unstructured":"Winkler K, Wanner C, Drechsler C, Lilienthal J, M\u00e4rz W, Krane V. Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients. Eur Heart J. 2008, 29:2092-9. 10.1093\/eurheartj\/ehn278","journal-title":"Eur Heart J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.12.017","article-title":"Association of NT-proBNP and BNP with future clinical outcomes in patients with ESKD: a systematic review and meta-analysis","volume":"76","author":"Harrison TG","year":"2020","unstructured":"Harrison TG, Shukalek CB, Hemmelgarn BR, et al.. Association of NT-proBNP and BNP with future clinical outcomes in patients with ESKD: a systematic review and meta-analysis. Am J Kidney Dis. 2020, 76:233-47. 10.1053\/j.ajkd.2019.12.017","journal-title":"Am J Kidney Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2007.101691","article-title":"N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements","volume":"54","author":"Guti\u00e9rrez OM","year":"2008","unstructured":"Guti\u00e9rrez OM, Tamez H, Bhan I, et al.. N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements. Clin Chem. 2008, 54:1339-48. 10.1373\/clinchem.2007.101691","journal-title":"Clin Chem"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/951629","article-title":"B-type natriuretic peptide in the critically ill with acute kidney injury","volume":"2011","author":"de Cal M","year":"2011","unstructured":"de Cal M, Haapio M, Cruz DN, et al.. B-type natriuretic peptide in the critically ill with acute kidney injury. Int J Nephrol. 2011, 2011:","journal-title":"Int J Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/370644-the-impact-of-volume-removal-by-hemodialysis-on-elevated-nt-probnp-levels-in-patients-with-hypervolemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T12:01:21Z","timestamp":1749384081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/370644-the-impact-of-volume-removal-by-hemodialysis-on-elevated-nt-probnp-levels-in-patients-with-hypervolemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,8]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.85554","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,8]]}}}